Ajax-Loading

Sino Biopharmaceutical Ltd - Deferred Long Term Liabilities

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.

The item "Deferred-Long-Term-Liabilities" stands at 772.46 Million Hong Kong Dollars as of 12/31/2021, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.45 percent compared to the value the year prior.
The 1 year change in percent is 10.45.
The 3 year change in percent is 52.97.
The 5 year change in percent is 500.40.

The Serie's long term average value is 536.99 Million Hong Kong Dollars. It's latest available value, on 12/31/2021, is 43.85 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 12/31/2021, is +500.40%.
The Serie's change in percent from it's maximum value, on 09/30/2021, to it's latest available value, on 12/31/2021, is 0.0%.

Deferred Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Deferred Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Deferred Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Deferred Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Deferred Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Deferred Long Term Liabilities280,205,508,085.11